Medication info
Ivetel Tablet (Irbesartan)

Ivetel Tablet (Irbesartan)

Prescription medicationTabletOral
Ingredient · strength
Irbesartan›150mg
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
White or almost white, oval, biconvex, film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200800339 · Notified 2008.01.08 · Insurance code 671702130

Summary

Main use
Treatment of essential hypertension and diabetic nephropathy with hypertension in patients with type 2 diabetes
Who takes it
Adults
Adult dose
This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in certain circumstances (such as at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be given concomitantly. The effect is enhanced particularly when coadministered with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Kidney disease in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be given concomitantly to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although dosage adjustment is generally not specifically required in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and diabetic nephropathy with hypertension in patients with type 2 diabetes

  • Essential hypertension
  • hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication effectively lowers blood pressure in patients with essential hypertension, aiding in blood pressure control. Additionally, it is used to slow the progression of kidney disease in patients with hypertension and kidney issues due to type 2 diabetes. This drug helps improve both blood pressure and kidney function, contributing to overall health.

How to take

Adult dose

This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in certain circumstances (such as at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be given concomitantly. The effect is enhanced particularly when coadministered with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Kidney disease in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be given concomitantly to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although dosage adjustment is generally not specifically required in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.

Precautions

This medication may cause serious harm to the fetus and newborn if used by pregnant women; therefore, it must be stopped immediately once pregnancy is confirmed. Patients allergic to this medication, those with severe liver impairment, or individuals with specific genetic disorders should not use it. Patients with severe diabetes or impaired kidney function, as well as those with a history of angioedema, should exercise caution. Elderly patients, those with hyperkalemia, patients with compromised liver function, and individuals with heart or cerebrovascular diseases should be especially careful when using this medication. Though generally mild and temporary, side effects may include dizziness, headache, fatigue, dyspepsia, and rash. Serious side effects, such as excessively low blood pressure, angioedema, renal failure, liver dysfunction, hypoglycemia, and myalgia may occur, so any symptoms should prompt immediate consultation with healthcare professionals. Patients with weak liver or kidney function may require dosage adjustments, and it is advisable to discontinue the drug 24 hours prior to surgery. Interactions may occur if taken with other antihypertensive drugs, diuretics, potassium supplements, or specific diabetes medications, so consulting a doctor or pharmacist is essential. Women who are pregnant or breastfeeding should ideally avoid this medication, and if it must be taken, breastfeeding should be discontinued. Safety in pediatric patients has not been established, thus it is not recommended for children. Overdosage may lead to hypotension and cardiac arrhythmias; immediate medical attention is necessary. Store this medication out of the reach of children, and do not transfer it to another container for safety. Be cautious while driving or operating machinery, as dizziness or fatigue may occur. Finally, the antihypertensive effect may vary among certain ethnic groups, as individual condition adjustments may be necessary.

Side effects

  • Respiratory infections
  • headache
  • musculoskeletal pain
  • dizziness
  • fatigue
  • diarrhea
  • cough
  • nausea/vomiting
  • musculoskeletal trauma
  • chest pain
Show 124 more
  • indigestion/heartburn
  • edema
  • abdominal pain
  • rash
  • tachycardia
  • anxiety/nervousness
  • upper urinary tract infection
  • fever
  • chills
  • facial edema
  • arm edema
  • flushing
  • heart murmur
  • myocardial infarction
  • angina
  • arrhythmia/conduction abnormalities
  • cardiac-respiratory arrest
  • heart failure
  • hypertensive crisis
  • itching
  • dermatitis
  • petechial hemorrhage
  • erythema
  • hives
  • sexual dysfunction
  • changes in sexual function
  • gout
  • constipation
  • oral lesions
  • gastroenteritis
  • abdominal distension
  • limb edema
  • muscle rigidity
  • arthritis
  • myalgia
  • joint stiffness
  • bursitis
  • muscle weakness
  • sleep disorders
  • paralysis
  • drowsiness
  • mood disorders
  • depression
  • sensory disturbances
  • tremors
  • transient ischemia
  • cerebrovascular accident
  • abnormal urination
  • prostate abnormalities
  • nasal bleeding
  • bronchitis
  • congestion
  • pulmonary congestion
  • shortness of breath
  • wheezing
  • visual impairment
  • auditory disturbances
  • ear infections
  • ear pain
  • conjunctivitis
  • eyelid abnormalities
  • ear abnormalities
  • dizziness
  • orthostatic dizziness
  • orthostatic hypotension
  • increased plasma creatine kinase
  • hyperkalemia
  • hypersensitivity reactions
  • rash
  • hives
  • angioedema
  • anaphylactic shock
  • anaphylactic reaction
  • weakness
  • diarrhea
  • indigestion
  • nausea
  • tinnitus
  • myalgia
  • increased plasma creatine kinase
  • arthralgia
  • tachycardia
  • hepatitis
  • abnormal liver function
  • renal failure
  • psoriasis
  • photosensitivity reactions
  • anemia
  • thrombocytopenia
  • hypoglycemia
  • angioedema
  • shock
  • syncope
  • loss of consciousness
  • renal failure
  • liver dysfunction
  • jaundice
  • hypoglycemia
  • rhabdomyolysis
  • myalgia
  • weakness
  • elevated creatine kinase
  • increased serum and urinary myoglobin
  • palpitations
  • constipation
  • shortness of breath
  • hypoaesthesia
  • hypertriglyceridemia
  • insomnia
  • taste disorders
  • dry mouth
  • abdominal distension
  • oral hemorrhage
  • increased sputum
  • decreased HDL
  • increased salivation
  • dry skin
  • itching
  • granulocytopenia
  • leukopenia
  • erectile dysfunction
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to protect it from air and moisture. Keep it in a cool, dry place below 30°C to maintain its effectiveness.

Appearance and packaging

Appearance

White or almost white, oval, biconvex, film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.